Does the ternary complex act as a secondary proton pump and a GTP synthase?

The ligand-receptor-G-protein ternary complex as a GTP-synthase. steady-state proton pumping and dose-response relationships for beta -adrenoceptors

Steady-state solutions are developed for the rate of G alpha.GTP production in a synthase model of the ligand-receptor-G-protein ternary complex activated by a ligand-receptor proton pumping mechanism. The effective rate, k(31), defining the proton transfer, phosphorylation and G alpha.GTP release is a controlling rate of the synthase in the presence of a ligand with an efficient mode of signal activation, the ligand-receptor interaction taking place under effectively equilibrium conditions. The composite rate, however, becomes an amplifying factor in any dose-response relationship. The amplification is a triple product of the rate, k(31), the equilibrium constant associated with the activation of the proton signal, K(act)and the fraction of agonist conformer transmitting the signal, f(*). Where the rate of activation of the proton signal becomes critically inefficient, the rate of activation, k(act 1)replaces k(31)K(act). A correlation between beta(1)-adrenergic receptor-stimulated GDP release and adenylate cyclase activation shows that this correlation is not unique to an exchange reaction. Within the initiating Tyr-Arg-Tyr receptor proton shuttle mechanism, the position of Arg(r156) paralleldictates the high-(R(p)) and low-(R(u)) ligand-binding affinities. These states are close to R(*)and R(0)of the equilibrium model (De Lean et al., 1980, J. Biol. Chem.255, 7108-7117). An increased rate of hydrogen ion diffusion into a receptor mutant can give rise to constitutive activity while increased rates of G-protein release and changes in receptor state balance can contribute to the resultant level of action. Constitutive action will arise from a faster rate of G-protein release alone if proton diffusion in the wild-type receptor contributes to a basal level of G-protein activation. Competitive ligand-receptor occupancy for constitutive mutants shows that, where the rate of G-protein activation from the proportion of ligand-occupied receptors is less than the equivalent rate that would be generated from this fraction by proton diffusion, inverse agonism will occur. Rate-dependent dose-responses developed for the proposed synthase mechanism give explicit definition to the operational model for partial agonism (Black & Leff, 1983, Proc. Roy. Soc. Lond. B220, 141-162). When comparable ligands have effectively identical conformational states at the transition state for signal activation, the antagonist component of the binding "in vitro" can be derived by multiplying the apparent binding constant by (1-e) where e is the maximum stimulatory response. This component should be consistent throughout the tissues.

Adaptation of pharmacomechanical coupling of vascular smooth muscle to chronic hypoxia

Hypoxia is one of the most common stresses that affect an organism's homeostasis. Although much is known of the mechanisms of the cellular and biochemical responses to acute hypoxia, relatively little is known of the mechanisms of the responses to prolonged or chronic hypoxia. Chronic hypoxia suppresses vascular smooth muscle contractility in many vascular beds. While the endothelium is likely to play a role, part of the mechanisms underlying chronic hypoxic-induced changes in vascular responses resides in the changes in receptor-mediated excitation-contraction coupling and/or signal transduction in the vascular smooth muscle. Recent studies have demonstrated that chronic hypoxia attenuates both receptor-second messenger and second messenger-contraction coupling efficiencies in the vascular smooth muscle. This suppression of pharmacomechanical coupling is likely to represent one of the adaptive mechanisms of vascular smooth muscle and to play an important role in an adjustment of vascular tone and blood flow under the stress of moderate chronic hypoxia.

Chronic hypoxia suppresses pharmacomechanical coupling of the uterine artery in near-term pregnant sheep

1. The role of inositol 1,4,5-trisphosphate (InsP3) in the reduced vascular responsiveness to 5-hydroxytryptamine (5-HT) caused by chronic hypoxia was examined in uterine arteries obtained from normoxic (control) and chronically hypoxic pregnant sheep (approximately 140 days gestation) maintained at high altitude (3820 m; arterial PO2, 60 mmHg) from 30 days gestation. 2. Chronic hypoxia significantly decreased uterine artery contractile sensitivity in that pD2 (-logEC50) for the contractile response to 5-HT was 7.19 +/- 0.15 and 6.62 +/- 0.12 (P < 0.05) in uterine arteries from normoxic and chronically hypoxic sheep, respectively. The intrinsic efficacy of the agonist was reduced by 75%. Although 5-HT2A receptor density (Bmax) in the uterine artery was not changed in chronically hypoxic sheep compared with normoxic sheep (32.0 +/- 9.8 vs. 31.9 +/- 5.9 fmol (mg protein)-1, respectively) as assessed from the saturation binding of [3H]ketanserin, the agonist binding affinity (pKA, -log of dissociation constant) was decreased from 6.25 +/- 0.07 in normoxic sheep to 5.85 +/- 0.08 in chronically hypoxic sheep (P < 0.05). 3. Chronic hypoxia did not change the time course of 5-HT-induced InsP3 synthesis but decreased its potency in inducing InsP3 synthesis, with the pD2 being 6.09 +/- 0.11 and 5.51 +/- 0.08 (P < 0.05) in uterine arteries from normoxic and chronically hypoxic sheep, respectively. The maximal response of 5-HT-induced InsP3 generation in the uterine artery was decreased from 251.3 +/- 24.2 pmol (mg protein)-1 in normoxic sheep to 146.6 +/- 11.3 pmol (mg protein)-1 in chronically hypoxic sheep (P < 0.05). Furthermore, the ability of the activated 5-HT receptors to couple InsP3 synthesis was significantly decreased in chronically hypoxic compared with normoxic sheep (280 +/- 10 vs. 450 +/- 20 fmol InsP3 (fmol receptor)-1, P < 0.01). In addition, for a given amount of InsP3 generated, the contractile force of the uterine artery was significantly less in chronically hypoxic sheep (0.82 +/- 0.08 g tension (pmol InsP3)-1) than that in normoxic sheep (1.28 +/- 0.05 g tension (pmol InsP3)-1) (P < 0.05). 4. These results suggest that chronic hypoxia suppresses pharmacomechanical coupling of the ovine uterine artery by inhibiting the efficiency of receptor-effector-contraction coupling. This suppression of the InsP3 pathway may play an important role in the adjustment of vascular tone and uterine blood flow in response to the stress of chronic hypoxia in late pregnancy.

Modelling and mutation studies on the histamine H1-receptor agonist binding site reveal different binding modes for H1-agonists: Asp116 (TM3) has a constitutive role in receptor stimulation

A modelling study has been carried out, investigating the binding of histamine (Hist), 2-methylhistamine (2-MeHist) and 2-phenylhistamine (2-PhHist) at two postulated agonistic binding sites on transmembrane domain 5 (TM5) of the histamine H1-receptor. For this purpose a conformational analysis study was performed on three particular residues of TM5, i.e., Lys200, Thr203 and Asn207, for which a functional role in binding has been proposed. The most favourable results were obtained for the interaction between Hist and the Lys200/Asn207 pair. Therefore, Lys200 was subsequently mutated and converted to an alanine, resulting in a 50-fold decrease of H1-receptor stimulation by histamine. Altogether, the data suggest that the Lys200/Asn207 pair is important for activation of the H1-receptor by histamine. In contrast, analogues of 2-PhHist seem to belong to a distinct subclass of histamine agonists and an alternative mode of binding is proposed in which the 2-phenyl ring binds to the same receptor location as one of the aromatic rings of classical histamine H1-antagonists. Subsequently, the binding modes of the agonists Hist, 2-MeHist and 2-PhHist and the H1-antagonist cyproheptadine were evaluated in three different seven-alpha-helical models of the H1-receptor built in homology with bacteriorhodopsin, but using three different alignments. Our findings suggest that the position of the carboxylate group of Asp116 (TM3) within the receptor pocket depends on whether an agonist or an antagonist binds to the protein; a conformational change of this aspartate residue upon agonist binding is expected to play an essential role in receptor stimulation.